Dodman Limited, specialists in the design, manufacture, installation and maintenance of processing systems for major food manufacturers, has selected our
Intelligent Bio Solutions has been granted a patent in the United Kingdom (UK) relating to its Intelligent Fingerprinting Drug Screening
A & F Sprinklers, one of the UK’s leading fire protection and automatic sprinkler systems specialists, has selected Intelligent Bio
Intelligent Bio Solutions has selected Human and Supplement Testing Australia (“HASTA”), Australia’s largest independent sports drug testing laboratory, as its
Intelligent Bio Solutions today announced the closing of its previously announced underwritten public offering. Ladenburg Thalmann & Co. Inc. acted
NEW YORK, NY, March 8, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a
NEW YORK, NY, March 07, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced that it is commencing an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock….
NEW YORK, NY, March 1, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced that on February 27, 2023, the Company received a notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)…
NEW YORK, February 16, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced that the Company has filed a 513(g) submission with the United States Food and Drug Administration (FDA) for its Intelligent Fingerprinting Drug Screening…
NEW YORK, February 14, 2023 — Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced its financial results for its fiscal second quarter ended December 31, 2022, and provided a business update. All amounts are expressed in U.S. dollars…
NEW YORK, February 7, 2023 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), today announced that Boughey Distribution (“Boughey”), one of the United Kingdom’s leading logistics providers to the food industry, has selected the on-the-spot fingerprint test from the Company’s subsidiary, Intelligent Fingerprinting, to support its random drug screening program, replacing its previous urine-based test….
NEW YORK, January 31, 2023 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), today announced that global garden equipment manufacturer Hozelock will implement drug tests utilizing fingerprint sweat-based technology from the Company’s subsidiary, Intelligent Fingerprinting, to promote employee safety. Hozelock will use the fingerprint sweat-based drug test to determine any recent employee use of…
NEW YORK, January 23, 2023 (GLOBE NEWSWIRE) – Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced it has successfully completed the review of results from Milestone 7, a phase of its biosensor platform development at the University of…
NEW YORK, Dec. 22, 2022 (GLOBE NEWSWIRE) – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point of care, today announced that it has closed a Regulation S private placement (the “Transaction”) for expected aggregate gross proceeds of $220,585. The…
NEW YORK, Dec. 21, 2022 (GLOBE NEWSWIRE) – Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions” or the “Company”) (Nasdaq: INBS), today announced that its Board of Directors has cancelled the Company’s annual meeting of stockholders (for fiscal year ended June 30, 2021) that was originally scheduled to be held on June 16, 2022(the “FY21 Annual Meeting”), but…
